Introduction to Psychedelic Pharmacology | On Demand
Psychedelic Psychopharmacology
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Description
Learn about Psychedelic Psychopharmacology in our 12-week reading and study group or on-demand webinar. See the individual courses for an in-depth description of each offering.
Learning Objectives
- Describe pharmacokinetic properties of psilocybin to predict potential drug interactions and adverse effects.
- Describe pharmacokinetic properties of ayahuasca to predict potential drug interactions and adverse effects.
- Describe pharmacokinetic properties of MDMA to predict potential drug interactions and adverse effects.
- Describe pharmacokinetic properties of ketamine to predict potential drug interactions and adverse effects.
- Explain how the pharmacodynamics of psilocybin affects clinical and serological biomarkers.
- Explain how the pharmacodynamics of ayahuasca affects clinical and serological biomarkers.
- Explain how the pharmacodynamics of MDMA affects clinical and serological biomarkers.
- Explain how the pharmacodynamics of ketamine affects clinical and serological biomarkers.
- Discuss the effects of psilocybin on neural network function.
- Discuss the effects of ayahuasca on neural network function.
- Discuss the effects of MDMA on neural network function.
- Discuss the effects of ketamine on neural network function.
